32 results on '"Kourakli, A"'
Search Results
2. Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry
3. Towards the improvement of the cognitive, motoric and academic skills of students with special educational needs using Kinect learning games
4. P102 - Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: NOVEL PREDICTIVE INDICATORS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC NEOPLASMS (HR-MDS) TREATED WITH 5-AZACYTIDINE: CUMULATIVE DATA FROM THE HELLENIC MDS STUDY GROUP
5. Real-World Data on the Use of Luspatercept in Greek Patients with Transfusion Dependent Thalassemia
6. Global vasomotor dysfunction and accelerated vascular aging in β-thalassemia major
7. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura: Real-World Multicenter Data on Re-Administration and Plasma Exchange Free Treatment
8. Combined flash- and glow-type chemiluminescent reactions for high-throughput genotyping of biallelic polymorphisms
9. POSB45 Cost of Illness (COI) Analysis of Sickle Cell Disease (SCD) in Greece
10. P062 Overexpansion of Th17 and Th1/17 cells in patients with myelodysplastic syndromes
11. An Epidemiological, Retrospective Cross-Sectional Study to Capture the Real-World Complication Burden, and Disease Management Paradigms in Transfusion-Dependent Beta-Thalassemia Adults in Greece: Interim Results of the Ulysses Study
12. The Prognostic Significance of Monocytopenia in Patients with Myelodysplastic Syndrome
13. Estimated Glomerular Filtration Rate Is an Independent Predictor of Outcome in High-Risk Myelodysplastic Syndrome (MDS) and Low Blast Count Acute Myeloid Leukaemia (AML) Patients Treated with Azacytidine (AZA). a Retrospective Study from the MDS Registry of the Hellenic MDS Study Group
14. Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group
15. Primary Bone Non-Hodgkin's Lymphoma: A Specific Clinical Entity with Aggressive Clinical Course and High Cure Rate - Retrospective Analysis of 102 Patients from Greece
16. Sickle-Cell Disease in Greece: Patient Reported Outcomes Related to Clinical Complications, Treatment Choices and Attitudes, Beliefs and Trends Affecting Potential Participation in Clinical Trials - a Greek National Multicentric Study
17. Characteristics of Long-Term Survival of Patients with MDS Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry
18. Hepatitis C Virus Infection, but Not Hepatic Iron Overload Is the Dominant Risk Factor for the Manifestation of Hepatocellular Carcinoma Among Greek Thalassemic Patients
19. Neurological Manifestations Due to Extramedullary Hematopoiesis in Greek Patients with Thalassemia Intermedia: Not Such a Rare Clinical Finding
20. The Clinical Significance of Chromosome 17 Abnormalities in Myelodysplastic Syndrome Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry
21. Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome
22. RAD Regimen Increases Bone Formation and Reduces Bone Resorption and Angiogenesis in Patients with Newly Diagnosed Myeloma: Results of a Phase 2 Study
23. Lenalidomide, Adriamycin, and Dexamethasone (RAD) As Induction Therapy for Patients with Newly Diagnosed Multiple Myeloma Who Are Eligible for Autologous Transplantation (ASCT): A Phase 2 Study from the Greek Myeloma Study Group
24. Overexpansion of Th17 and Th1/17 Cells in Patients with Myelodysplastic Syndrome
25. G80S-linked ferroportin disease: The first clinical description in a Greek family
26. P-83 Expression of MIP-1α protein in 65 patients with myelodysplastic syndrome (MDS). A study of the Greek MDS study group
27. HCV infection in adult patients with B-thalassemia major: 10 years follow up
28. Endothelial function is impaired and intina-media thickness of the common carotid arterial wall is increased in patients with β-thalassemia major
29. (D6) IL-3 plus IL-6 improve hematopoiesis in long-term bone marrow cultures (LTBMC) of patients with myelodysplastic syndromes (MDS)
30. (A5) Chronic neutrophilic leukemia with dysplastic features (CNL-D). A report of seven patients
31. 103 Extensive apoptosis of CD34+ marrow cells in patients with mds is related to low colony forming cell number and probably to hematopoietic deficiency
32. 66 Prognostic significance of serum protein electrophoresis pattern changes in patients with myelodysplastic syndromes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.